Utilisation of Angiox® in European Practice

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2019 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-05-31

Study Completion Date

2010-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to determine utilisation patterns in patients receiving Angiox® in participating European centres. Additionally, through the collection of descriptive safety and outcomes data, this study will contribute to the Risk Management strategy for Europe

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX

NCT01433627

Acute Coronary Syndromes STEMI NSTEMI

UNKNOWN PHASE3

Belgian Real Life Non-interventional Study (NIS) on Xarelto in Non-valvular Atrial Fibrillation (AF) Patients Treated for the Prevention of Stroke and Systemic Embolism

NCT01855139

Atrial Fibrillation

COMPLETED

Comparative Study of ALX-0081 Versus GPIIb/IIIa Inhibitor in High Risk Percutaneous Coronary Intervention (PCI) Patients

NCT01020383

Unstable Angina Non ST Segment Elevation Myocardial Infarction (NSTEMI) Stable Angina (Associated With High Risk PCI)

COMPLETED PHASE2

Study Evaluating How Patients With Acute Coronary Syndrome Are Managed During 2 Years After Discharge

NCT01171404

ACS Acute Coronary Syndrome Myocardial Infarction +2 more

COMPLETED

Parenteral Antiplatelet Agents in Real-world Spanish PCI Patients

NCT05193019

Ischemic Heart Disease Acute Coronary Syndrome

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stable Angina (SA) NSTE-ACS (NSTEMI and UA) STEMI (STE-ACS)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Eligible for, and receive treatment with Angiox®.
* Willing and able to provide written informed consent to the use of their data in accordance with relevant local Data Protection laws, policies and regulations

Exclusion Criteria

* Participation in other interventional clinical research studies involving the evaluation of investigational drugs, including Angiox®, or devices at the time of enrolment.
* Patients not eligible for treatment for Angiox®.

Eligible Sex

ALL

Accepts Healthy Volunteers

No